Veterinary Point Of Care Diagnostics Market Size, Share, Trends, Innovations, Outlook 2022-2030

The global Veterinary Point Of Care Diagnostics market size is expected to be worth around US$ 5.69 billion by 2030, according to a new report by Vision Research Reports.

The global Veterinary Point Of Care Diagnostics market size was valued at US$ 2.15 billion in 2020 and is anticipated to grow at a CAGR of 12.3% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39084

Report Coverage

Report Scope Details
Market Size US$ 5.69 billion by 2030
Growth Rate CAGR of 12.3% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Animal Type, Product, Sample type, Testing category, Indication, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned IDEXX Laboratories; Zoetis; Virbac; Heska Corporation; Thermo Fisher Scientific, Inc.; Neogen Corporation; Mindray; Esaote SpA; FUJIFILM Corporation; Woodley Equipment Company Ltd.

Growth Factors

Technological advancements, strategic initiatives by key market players, rising pet population and humanization, the need to reduce antimicrobial resistance, and the expansion of service offerings by vet clinics are key factors driving the market. Heska, for instance, allocates its R&D budget for developing new Analyzer and Diagnostics Platforms, expanding the menu of analyzer platforms, upgrading the cycle to already installed platforms, and other in-house inventions. The market witnessed a slowdown in sales, reduced demand, and logistical challenges due to the COVID-19 pandemic. The uncertainty was exacerbated by the changing lockdown measures, guidelines on the movement of people and goods, remote work, and self-quarantine conditions.

Several key animal health companies also registered increased profits during 2020. This was owing to the deployment of various strategic initiatives such as diverting their resources to profitable segments to ensure business continuity, acquisitions, and the launch of new products. Heska, for instance, reported 97.4% of growth in its revenue during the first quarter of 2021. IDEXX Laboratories, Inc. reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment, during 2020.

By Sample Type Analysis

The blood/plasma/serum segment held the largest revenue share of over 40.0% in 2020. According to the Kirkwood Animal Hospital in the U.S., regular blood tests are recommended as a key part of a companion animal’s overall wellness program.

The urine segment is expected to grow at the fastest rate over the forecast period. For instance, ACON Laboratories, Inc. offers CentriVet URS Reagent Strips for Urinalysis.

The reagent strips can be used for detecting 10 parameters, including bilirubin and urobilinogen for signs of liver disease, leukocytes and nitrites for urinary tract infections, and glucose and ketone for diabetes mellitus.

By Product Analysis

The consumables, reagents, and kits segment accounted for the largest share of more than 55.0% in 2020. This is owing to large product availability, subscription-based or repetitive payments sales model for reagents and consumables, and other initiatives by key companies.

The instruments and devices segment is projected to expand at the fastest rate of over 11.6% in the forecast period owing to growing product enhancements and demand for these products. Pentra C400 clinical chemistry analyzer by HORIBA, Ltd., based in Japan, for instance, can be used for routine to specific tests owing to its 55 on-board assays.

By Testing Category Analysis

Parasitology dominated the market with a revenue share of over 17.0% in 2020. The hematology segment is estimated to expand at the fastest CAGR of 12.0% over the forecast period.

Zoetis, for instance, launched Imagyst in 2020 to enable vets to make fast and accurate diagnoses at the point of care by automating the fecal examination to detect endoparasitic eggs, cysts, and oocysts.

By End-use Analysis

Veterinary hospitals and clinics held the largest revenue share of over 50.0% in 2020. This is attributed to a higher volume of patients received in these facilities, growing adoption of point of care devices by vet clinics, and wide diagnostic services offerings.

The home care settings segment is expected to register the highest growth rate of 12.9% from 2021 to 2030 due to the rising product launches in this category and pet expenditure.

By Animal Type Analysis

Companion animals dominated the market with a revenue share of over 60.0% in 2020. The livestock animals segment is projected to grow at the fastest rate over the forecast period.

This is attributed to the rising pet population, increasing expenditure, growing adoption of pet insurance, and the need to secure food sources by safeguarding the health of livestock animals.

Dogs and cats, for example, dominate the pet population in the U.S. as per the National Pet Owners Survey of 2019 to 2020 by the American Pet Products Association (APPA). Americans were estimated to have spent over USD 100 billion on pets in 2020.

By Indication Analysis

The infectious disease segment held the largest revenue share of about 40.0% in 2020. The general ailments segment is estimated to expand at the highest rate of 11.4% over the forecast period.

The key factors contributing to this growth include the growing prevalence of acute and chronic diseases in animals, the longer lifespan of pets, product advancements, and pet humanization.

Independent Vetcare Ltd.’s South Devon Veterinary Hospital in the U.K. offers a full range of diagnostic endoscopy services using flexible and rigid endoscopes as well as video endoscopes.

By Regional Analysis

North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.

North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.

Key Players

  • IDEXX Laboratories
  • Zoetis
  • Virbac
  • Heska Corporation
  • Thermo Fisher Scientific, Inc.
  • Neogen Corporation
  • Mindray
  • Esaote SpA
  • FUJIFILM Corporation
  • Woodley Equipment Company Ltd.

Market Segmentation

  • By Animal Type
    • Companion Animals
      • Dogs
      • Cats
      • Horses
      • Others
    • Livestock Animals
      • Cattle
      • Swine
      • Poultry
      • Others
  • By Product
    • Consumables, Reagents, & Kits
    • Instruments & Devices
  • By Sample Type
    • Blood/Plasma/Serum
    • Urine
    • Fecal
    • Others
  • By Testing Category
    • Hematology
    • Diagnostic Imaging
    • Bacteriology
    • Virology
    • Cytology
    • Clinical Chemistry
    • Parasitology
    • Serology
    • Others
  • By Indication
    • Infectious Disease
    • General Ailments
    • Others
  • By End-use
    • Veterinary Hospitals & Clinics
    • Home Care Settings
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • Israel

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39084

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Point Of Care Diagnostics Market, By Animal Type

7.1.  Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030

7.1.1.    Companion Animals

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Livestock Animals

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Veterinary Point Of Care Diagnostics Market, By Product

8.1.  Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030

8.1.1.    Consumables, Reagents, & Kits

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Instruments & Devices

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Veterinary Point Of Care Diagnostics Market, By Sample Type

9.1.  Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030

9.1.1.    Blood/Plasma/Serum

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Urine

9.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Veterinary Point Of Care Diagnostics Market, By Testing Category

10.1.        Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030

10.1.1.  Hematology

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Diagnostic Imaging

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Bacteriology

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Virology

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Cytology

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Virology

10.1.6.1.      Market Revenue and Forecast (2017-2030)

10.1.7.  Clinical Chemistry

10.1.7.1.      Market Revenue and Forecast (2017-2030)

10.1.8.  Parasitology

10.1.8.1.      Market Revenue and Forecast (2017-2030)

10.1.9.  Serology

10.1.9.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Veterinary Point Of Care Diagnostics Market, By Indication

11.1.        Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030

11.1.1.  Infectious Disease

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  General Ailments

11.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Veterinary Point Of Care Diagnostics Market, By End-use

12.1.        Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030

12.1.1.  Veterinary Hospitals & Clinics

12.1.1.1.      Market Revenue and Forecast (2017-2030)

12.1.2.  Home Care Settings

12.1.2.1.      Market Revenue and Forecast (2017-2030)

Chapter 13.      Global Veterinary Point Of Care Diagnostics  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.2.  Market Revenue and Forecast, by Product (2017-2030)

13.1.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.1.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.1.8.  Rest of North America

13.1.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.1.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.1.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.1.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.1.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.1.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.        Europe

13.2.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.2.  Market Revenue and Forecast, by Product (2017-2030)

13.2.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.2.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.2.7.  UK

13.2.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.8.  Germany

13.2.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.9.  France

13.2.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.2.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.2.10.               Rest of Europe

13.2.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.2.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.2.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.2.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.2.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.2.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.2.  Market Revenue and Forecast, by Product (2017-2030)

13.3.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.3.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.8.  China

13.3.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.9.  Japan

13.3.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.3.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.3.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.3.10.               Rest of APAC

13.3.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.3.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.3.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.3.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.3.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.2.  Market Revenue and Forecast, by Product (2017-2030)

13.4.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.4.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.8.  North Africa

13.4.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.9.  South Africa

13.4.9.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.9.2.      Market Revenue and Forecast, by Product (2017-2030)

13.4.9.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.9.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.9.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.4.9.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.4.10.               Rest of MEA

13.4.10.1.   Market Revenue and Forecast, by Animal Type (2017-2030)

13.4.10.2.   Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3.   Market Revenue and Forecast, by Sample Type (2017-2030)

13.4.10.4.   Market Revenue and Forecast, by Testing Category (2017-2030)

13.4.10.5.   Market Revenue and Forecast, by Indication (2017-2030)

13.4.10.6.   Market Revenue and Forecast, by End-use (2017-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.2.  Market Revenue and Forecast, by Product (2017-2030)

13.5.3.  Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.4.  Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.5.  Market Revenue and Forecast, by Indication (2017-2030)

13.5.6.  Market Revenue and Forecast, by End-use (2017-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.7.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.7.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.7.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.7.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.7.6.      Market Revenue and Forecast, by End-use (2017-2030)

13.5.8.  Rest of LATAM

13.5.8.1.      Market Revenue and Forecast, by Animal Type (2017-2030)

13.5.8.2.      Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3.      Market Revenue and Forecast, by Sample Type (2017-2030)

13.5.8.4.      Market Revenue and Forecast, by Testing Category (2017-2030)

13.5.8.5.      Market Revenue and Forecast, by Indication (2017-2030)

13.5.8.6.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 14.  Company Profiles

14.1.              IDEXX Laboratories

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Zoetis

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              Virbac

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Heska Corporation

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Thermo Fisher Scientific, Inc.

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              Neogen Corporation

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Mindray

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Esaote SpA

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              FUJIFILM Corporation

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

14.10.           Woodley Equipment Company Ltd.

14.10.1.               Company Overview

14.10.2.               Product Offerings

14.10.3.               Financial Performance

14.10.4.               Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

16.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39084

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com